Alexandra M. Patron

Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer

R. Harvey, Michael Berger, J. Seligson, 2020, The Annals of pharmacotherapy.